INNOVUS PHARMACEUTICALS, INC. Professional Fees
INNOVUS PHARMACEUTICALS, INC. reported Professional Fees of $219.01 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2013-05-10
- INNOVUS PHARMACEUTICALS, INC. professional fees for the quarter ending 2013-03-31 was $219.01K, a 388.63% increase year-over-year.
- INNOVUS PHARMACEUTICALS, INC. professional fees for the quarter ending 2012-12-31 was $29.12K, a 49.59% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. professional fees for the quarter ending 2012-09-30 was $51.87K, a 121.87% increase year-over-year.
- INNOVUS PHARMACEUTICALS, INC. professional fees for the quarter ending 2012-06-30 was $39.44K, a 4.10% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. professional fees for fiscal 2012 was $163.96K, a 24.89% increase from fiscal 2011.
- INNOVUS PHARMACEUTICALS, INC. professional fees for fiscal 2011 was $131.28K.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month | Professional Fees 38 month | Professional Fees 44 month | Professional Fees 44 month as first filed | Professional Fees 47 month | Professional Fees 50 month | Professional Fees 53 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $219.01K 10-Q · filed 2013-05-10 | $248.13K derived: sum of 2 quarters · filed 2013-05-10 | $300.01K derived: sum of 3 quarters · filed 2013-05-10 | $339.44K derived: sum of 4 quarters · filed 2013-05-10 | $514.25K 10-Q · filed 2013-05-10 | |||||
| 2012-12-31 | $29.12K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-03-27 | $80.99K derived: sum of 2 quarters · filed 2013-03-27 | $120.43K derived: sum of 3 quarters · filed 2013-03-27 | $163.96K 10-K/A · filed 2013-03-27 | $295.23K 10-K/A · filed 2013-03-27 | |||||
| 2012-09-30 | $51.87K 10-Q · filed 2012-10-24 | $91.31K derived: sum of 2 quarters · filed 2012-10-24 | $134.83K 10-Q · filed 2012-10-24 | $193.89K derived: sum of 4 quarters · filed 2013-05-10 | $266.11K 10-Q · filed 2012-10-24 | |||||
| 2012-06-30 | $39.44K 10-Q/A · filed 2012-10-05 | $82.96K 10-Q/A · filed 2012-10-05 | $142.02K derived: sum of 3 quarters · filed 2013-05-10 | $165.40K derived: sum of 4 quarters · filed 2013-05-10 | $214.24K 10-Q/A · filed 2012-10-05 | $436.31K 10-Q/A · filed 2012-09-05 | ||||
| 2012-03-31 | $44.82K 10-Q · filed 2013-05-10 | $102.59K derived: sum of 2 quarters · filed 2013-05-10 | $125.97K derived: sum of 3 quarters · filed 2013-05-10 | $167.09K derived: sum of 4 quarters · filed 2013-05-10 | ||||||
| 2011-12-31 | $57.76K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-03-27 | $81.14K derived: sum of 2 quarters · filed 2013-03-27 | $122.27K derived: sum of 3 quarters · filed 2013-03-27 | $131.28K 10-K/A · filed 2013-03-27 | $131.28K 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $23.38K 10-Q · filed 2012-10-24 | $64.50K derived: sum of 2 quarters · filed 2012-10-24 | $73.51K 10-Q · filed 2012-10-24 | |||||||
| 2011-06-30 | $41.12K 10-Q/A · filed 2012-10-05 | $50.13K 10-Q/A · filed 2012-10-05 |